Specify a stock or a cryptocurrency in the search bar to get a summary
Enzo Biochem Inc
ENZEnzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company also licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. The company was incorporated in 1976 and is headquartered in Farmingdale, New York. Address: 21 Executive Blvd, Farmingdale, NY, United States, 11735
Analytics
WallStreet Target Price
5.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ENZ
Dividend Analytics ENZ
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ENZ
Stock Valuation ENZ
Financials ENZ
Results | 2019 | Dynamics |